Dimethylaminopathenolide (DMAPT), a Parthenolide analogue that inhibits NF-κB activity by preventing the degradation of IκB-α and IκB-β, increases the sensitivity of PCa cells to X-rays in vitro and in vivo [142]. The gene discussed is NFKB1; the disease is posterior cortical atrophy.